Thank you.
I have just a quick question. In terms of the delisting, Mr. Dinsdale—just to follow up—since OxyContin was delisted in 2012, the number of clients receiving long-acting opioids has actually declined by 10%, and that was the entire purpose of removing a number of drugs from the formulary. So, for instance, generic Ritalin and OxyContin were removed, Demerol was removed, Tylenol with codeine was removed, but at the same time, alternative therapies that have a lower risk of abuse have had more open access.
Have you noticed that?